Acrivon Therapeutics, Inc. — 4 Filings
144 4 filings on record
This page lists all 4 filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 144 4 documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0000905148-26-001118 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001115 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001117 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001119 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001116 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001121 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001120 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0000905148-26-001010 | Feb 24, 2026 | Feb 21, 2026 |
| 4 | FORM 4 | 0000905148-26-000939 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000934 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000935 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000936 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | FORM 4 | 0000905148-26-000937 | Feb 18, 2026 | Feb 14, 2026 |
| 4 | — | 0000905148-26-000281 | Jan 21, 2026 | Jan 17, 2026 |
| 4 | — | 0000905148-26-000226 | Jan 16, 2026 | Jan 14, 2026 |
| 4 | — | 0000905148-26-000225 | Jan 16, 2026 | Jan 14, 2026 |
| 4 | — | 0000905148-26-000212 | Jan 15, 2026 | Jan 13, 2026 |
| 4 | — | 0000905148-25-004179 | Nov 25, 2025 | Nov 21, 2025 |
| 4 | — | 0000905148-25-004131 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004127 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004128 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004129 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-004130 | Nov 18, 2025 | Nov 14, 2025 |
| 4 | — | 0000905148-25-003637 | Oct 21, 2025 | Oct 17, 2025 |
| 4 | — | 0000905148-25-003507 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | — | 0000905148-25-003506 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | — | 0000905148-25-003121 | Aug 25, 2025 | Aug 21, 2025 |
| 4 | — | 0000905148-25-003040 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003041 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003042 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003039 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-003043 | Aug 18, 2025 | Aug 14, 2025 |
| 4 | — | 0000905148-25-002732 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | — | 0000905148-25-002493 | Jul 21, 2025 | Jul 17, 2025 |
| 4 | — | 0001415889-25-017627 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-002170 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-002171 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-002177 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-002172 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-002173 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-002174 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | — | 0000905148-25-001900 | May 23, 2025 | May 21, 2025 |
| 4 | — | 0000905148-25-001824 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0000905148-25-001820 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0000905148-25-001821 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0000905148-25-001822 | May 16, 2025 | May 14, 2025 |
| 4 | — | 0000905148-25-001823 | May 16, 2025 | May 14, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-008341 | May 1, 2025 | Apr 30, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-008214 | Apr 29, 2025 | Apr 25, 2025 |
| 4 | — | 0000905148-25-001257 | Apr 18, 2025 | Apr 17, 2025 |